By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Orexo AB 

Box 303

Uppsala    SE-751 05  Sweden
Phone: 46-0-18-780-88-00 Fax: 46-0-18-780-88-88



Company News
Orexo (ORXOF): Issue And Repurchase Of Class C Shares 9/22/2016 10:54:48 AM
Orexo (ORXOF) Completes 1,080 Patient REZOLV Study And Reports On Improved Treatment Of Opioid Dependent Patients 9/2/2016 9:36:47 AM
Orexo (ORXOF): Interim Report January-June 2016 7/12/2016 10:48:45 AM
Orexo (ORXOF) Welcomes Changes From U.S. Health And Human Services (HHS) Announcement Increasing Treatment Access For Opioid-Dependent Patients 7/8/2016 8:38:57 AM
Orexo (ORXOF) Welcomes Increased Access To Treatment For Patients With Opioid Dependence In The U.S. 7/7/2016 10:02:54 AM
Mundipharma AG Obtains Global (Ex-US) Rights To Orexo (ORXOF)’s Opioid Dependence Treatment Zubsolv (Buprenorphine And Naloxone) 6/30/2016 11:38:55 AM
Orexo (ORXOF) To Present At Jefferies 2016 Healthcare Conference, NYC 5/31/2016 11:45:55 AM
Orexo (ORXOF): Interim Report January-March 2016 4/21/2016 11:16:48 AM
Report From Orexo (ORXOF)’s Annual General Meeting, 15 April 2016 4/18/2016 11:50:58 AM
AstraZeneca PLC (AZN) Snaps Up All Rights to Orexo (ORXOF)'s OX-CLI Project 3/17/2016 6:03:31 AM